Szmitkowski Maciej相关文献与解析，生知库

Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.

基于ROC分析的细胞因子M-CSF、金属蛋白酶2（MMP-2）和组织抑制剂-2（TIMP-2）在宫颈癌患者中的诊断效能

Lubowicka Emilia, Zbucka-Kretowska Monika, Sidorkiewicz Iwona, Zajkowska Monika, Gacuta Ewa, Puchnarewicz Andrzej, Chrostek Lech, Szmitkowski Maciej, Åawicki SÅawomir

细胞生物学

Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock

髓系细胞表达的可溶性触发受体-1在脓毒症、重症脓毒症和脓毒性休克中的诊断效能

期刊:Archives of Medical Science

影响因子:3.3

doi:10.5114/aoms.2018.73090

Jedynak, Monika; Siemiatkowski, Andrzej; Milewski, Robert; Mroczko, Barbara; Szmitkowski, Maciej

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

人血浆中血管内皮生长因子A、血管内皮生长因子C、血管内皮生长因子D及其可溶性受体VEGFR-2的水平，以及这些参数作为乳腺癌诊断肿瘤标志物的适用性

期刊:Pathology & Oncology Research

影响因子:2.3

doi:10.1007/s12253-018-0527-0

Zajkowska, Monika; Lubowicka, Emilia; Fiedorowicz, Wojciech; Szmitkowski, Maciej; Jamiołkowski, Jacek; Ławicki, Sławomir

Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock.

血清可溶性TREM-1水平可以早期预测脓毒症、重症脓毒症和脓毒性休克患者的死亡率

期刊:Archivum Immunologiae et Therapiae Experimentalis

影响因子:3.9

doi:10.1007/s00005-017-0499-x

Jedynak Monika, Siemiatkowski Andrzej, Mroczko Barbara, Groblewska Magdalena, Milewski Robert, Szmitkowski Maciej

其它

发表日期：2018

文献求助收藏

Activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in sera of patients with hepatitis C

丙型肝炎患者血清中乙醇脱氢酶同工酶和醛脱氢酶的活性

期刊:Archives of Medical Science

影响因子:3.3

doi:10.5114/aoms.2016.60406

Jelski, Wojciech; Strumnik, Anna; Orywal, Karolina; Lapinski, Tadeusz W; Swiderska, Magdalena; Szmitkowski, Maciej

肝炎

发表日期：2018

文献求助收藏

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.

基于ROC分析的人血浆中血管内皮生长因子、基质金属蛋白酶9和基质金属蛋白酶组织抑制剂1的水平及其作为宫颈癌诊断肿瘤标志物的适用性

期刊:Cancer Control

影响因子:2.6

doi:10.1177/1073274818789357

Zajkowska Monika, Zbucka-KrÄtowska Monika, Sidorkiewicz Iwona, Lubowicka Emilia, BÄdkowska GraÅ¼yna Ewa, Gacuta Ewa, Szmitkowski Maciej, Åawicki SÅawomir

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients.

对银屑病患者中选定的基质金属蛋白酶 (MMP) 和金属蛋白酶组织抑制剂 (TIMP) 进行 ROC 分析

期刊:Postepy Dermatologii I Alergologii

影响因子:1.7

doi:10.5114/ada.2018.75238

Glazewska Edyta K, Niczyporuk Marek, Lawicki Slawomir, Szmitkowski Maciej, Zajkowska Monika, Donejko Magdalena, Przylipiak Andrzej

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.

MMP-7 和 TIMP-1 的血浆水平在实验室诊断和鉴别选定的上皮性卵巢癌组织学类型中的应用

期刊:Journal of Ovarian Research

影响因子:4.2

doi:10.1186/s13048-017-0338-z

BÄdkowska GraÅ¼yna Ewa, Gacuta Ewa, Zajkowska Monika, GÅaÅ¼ewska Edyta Katarzyna, Osada Joanna, Szmitkowski Maciej, Chrostek Lech, DÄ browska Milena, Åawicki SÅawomir

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer.

血浆中基质金属蛋白酶 MMP-7 和 MMP-26 的浓度作为乳腺癌的诊断生物标志物

Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer.

血浆中 MMP-10 的水平可能是乳腺癌早期阶段的预后标志物

Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.

基于ROC分析的细胞因子M-CSF、金属蛋白酶2（MMP-2）和组织抑制剂-2（TIMP-2）在宫颈癌患者中的诊断效能

Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock

髓系细胞表达的可溶性触发受体-1在脓毒症、重症脓毒症和脓毒性休克中的诊断效能

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer

人血浆中血管内皮生长因子A、血管内皮生长因子C、血管内皮生长因子D及其可溶性受体VEGFR-2的水平，以及这些参数作为乳腺癌诊断肿瘤标志物的适用性

Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock.

血清可溶性TREM-1水平可以早期预测脓毒症、重症脓毒症和脓毒性休克患者的死亡率

Activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in sera of patients with hepatitis C

丙型肝炎患者血清中乙醇脱氢酶同工酶和醛脱氢酶的活性

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.

基于ROC分析的人血浆中血管内皮生长因子、基质金属蛋白酶9和基质金属蛋白酶组织抑制剂1的水平及其作为宫颈癌诊断肿瘤标志物的适用性

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients.

对银屑病患者中选定的基质金属蛋白酶 (MMP) 和金属蛋白酶组织抑制剂 (TIMP) 进行 ROC 分析

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.

MMP-7 和 TIMP-1 的血浆水平在实验室诊断和鉴别选定的上皮性卵巢癌组织学类型中的应用